• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

Futrex Incorporated - Close Out Letter 7/22/13


Department of Health and Human Services' logoDepartment of Health and Human Services

 Food and Drug Administration
Baltimore District Office
Central Region
6000 Metro Drive
Baltimore, MD 21201-2199
Telephone: (410) 779-5455
             FAX: (410) 779-5705



July 22, 2013

Ms. Carole R. Rosenthal
Futrex, Inc.
130 Western Maryland Parkway
Hagerstown, MD 21740

Dear Ms. Rosenthal,

On June 17, 2013, The Food and Drug Administration completed an evaluation of your firm's corrective actions in response to our Warning Letter (#385318), dated February 5, 2013. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.




CDR Rochelle B. Young, RPh, MSA
Compliance Officer, Baltimore District Office